DK3428274T3 - Anvendelse af nukleosominteragerende proteindomæner til forbedring af målrettet genommodifikation - Google Patents
Anvendelse af nukleosominteragerende proteindomæner til forbedring af målrettet genommodifikation Download PDFInfo
- Publication number
- DK3428274T3 DK3428274T3 DK18182999.5T DK18182999T DK3428274T3 DK 3428274 T3 DK3428274 T3 DK 3428274T3 DK 18182999 T DK18182999 T DK 18182999T DK 3428274 T3 DK3428274 T3 DK 3428274T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleosominating
- genomation
- modification
- protein domains
- improve targeted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762531222P | 2017-07-11 | 2017-07-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3428274T3 true DK3428274T3 (da) | 2021-11-15 |
Family
ID=62916578
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18182999.5T DK3428274T3 (da) | 2017-07-11 | 2018-07-11 | Anvendelse af nukleosominteragerende proteindomæner til forbedring af målrettet genommodifikation |
| DK21193940.0T DK3988656T3 (da) | 2017-07-11 | 2018-07-11 | Anvendelse af nukleosom-interagerende proteindomæner til at forbedre målrettet genommodifikation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21193940.0T DK3988656T3 (da) | 2017-07-11 | 2018-07-11 | Anvendelse af nukleosom-interagerende proteindomæner til at forbedre målrettet genommodifikation |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US10604752B2 (da) |
| EP (2) | EP3988656B9 (da) |
| JP (3) | JP6994560B2 (da) |
| KR (3) | KR102655021B1 (da) |
| CN (1) | CN111183226A (da) |
| AU (3) | AU2018299995B2 (da) |
| CA (1) | CA3066790C (da) |
| DK (2) | DK3428274T3 (da) |
| ES (2) | ES2901629T3 (da) |
| FI (1) | FI3988656T3 (da) |
| GB (3) | GB2598847B (da) |
| IL (2) | IL271197B2 (da) |
| LT (2) | LT3428274T (da) |
| PL (2) | PL3988656T3 (da) |
| PT (2) | PT3988656T (da) |
| SG (1) | SG11201911864PA (da) |
| WO (1) | WO2019014230A1 (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180250424A1 (en) | 2014-10-10 | 2018-09-06 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| US20190127713A1 (en) | 2016-04-13 | 2019-05-02 | Duke University | Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use |
| SG11201911864PA (en) | 2017-07-11 | 2020-01-30 | Sigma Aldrich Co Llc | Using nucleosome interacting protein domains to enhance targeted genome modification |
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US10767193B2 (en) * | 2018-02-15 | 2020-09-08 | Sigma-Aldrich Co. Llc | Engineered CAS9 systems for eukaryotic genome modification |
| WO2019204766A1 (en) | 2018-04-19 | 2019-10-24 | The Regents Of The University Of California | Compositions and methods for gene editing |
| WO2020036653A2 (en) * | 2018-04-25 | 2020-02-20 | The Regents Of The University Of California | Improved method for homology directed repair in cells |
| CA3102676A1 (en) | 2018-06-04 | 2019-12-12 | University Of Copenhagen | Mutant cpf1 endonucleases |
| CA3104856A1 (en) | 2018-06-29 | 2020-01-02 | Editas Medicine, Inc. | Synthetic guide molecules, compositions and methods relating thereto |
| CN111718418B (zh) * | 2019-03-19 | 2021-08-27 | 华东师范大学 | 一种增强基因编辑的融合蛋白及其应用 |
| CN111718420B (zh) * | 2019-03-19 | 2021-09-14 | 华东师范大学 | 一种用于基因治疗的融合蛋白及其应用 |
| WO2020187272A1 (zh) * | 2019-03-19 | 2020-09-24 | 上海邦耀生物科技有限公司 | 一种用于基因治疗的融合蛋白及其应用 |
| SG11202111982UA (en) * | 2019-05-13 | 2021-11-29 | Emd Millipore Corp | Synthetic self-replicating rna vectors encoding crispr proteins and uses thereof |
| US20230279373A1 (en) * | 2019-09-09 | 2023-09-07 | Beam Therapeutics Inc. | Novel crispr enzymes, methods, systems and uses thereof |
| EP4127179A4 (en) * | 2020-05-08 | 2025-07-23 | Univ Duke | CHROMATIN REMODELERS TO ENHANCE TARGETED GENE ACTIVATION |
| WO2021224506A1 (en) * | 2020-05-08 | 2021-11-11 | Universitat Pompeu Fabra | Crispr-cas homology directed repair enhancer |
| WO2022059928A1 (ko) * | 2020-09-21 | 2022-03-24 | 고려대학교 산학협력단 | 신규의 개량된 염기 편집 또는 교정용 융합단백질 및 이의 용도 |
| EP4230737A4 (en) * | 2020-09-21 | 2024-07-24 | Korea University Research and Business Foundation | NOVEL IMPROVED BASIC EDITING OR REVISION FUSION PROTEIN AND USE THEREOF |
| KR102699756B1 (ko) * | 2020-09-24 | 2024-08-29 | 고려대학교 산학협력단 | 편집 효율이 향상된 프라임 편집 기반 유전자 교정용 조성물 및 이의 용도 |
| AU2021374974A1 (en) * | 2020-11-06 | 2023-05-25 | Pairwise Plants Services, Inc. | Compositions and methods for rna-encoded dna-replacement of alleles |
| CN114507689B (zh) * | 2022-01-27 | 2024-01-16 | 山东大学 | 一种提高真核生物基因编辑效率的方法及其应用 |
| CN115716880A (zh) * | 2022-12-07 | 2023-02-28 | 云舟生物科技(广州)股份有限公司 | 一种核定位荧光蛋白及其应用 |
| CN115948465B (zh) * | 2022-12-16 | 2025-09-19 | 中国农业科学院北京畜牧兽医研究所 | 猪hat1基因修饰系统及应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002360424A1 (en) | 2001-11-26 | 2003-06-10 | Advanced Cell Technology, Inc. | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| CA2522819A1 (en) | 2003-04-22 | 2004-11-04 | Immunomedics, Inc. | Polyvalent protein complex |
| WO2013152220A2 (en) | 2012-04-04 | 2013-10-10 | Life Technologies Corporation | Tal-effector assembly platform, customized services, kits and assays |
| EP3494997B1 (en) * | 2012-07-25 | 2019-09-18 | The Broad Institute, Inc. | Inducible dna binding proteins and genome perturbation tools and applications thereof |
| KR102479178B1 (ko) | 2012-12-06 | 2022-12-19 | 시그마-알드리치 컴퍼니., 엘엘씨 | Crispr-기초된 유전체 변형과 조절 |
| US20140273230A1 (en) | 2013-03-15 | 2014-09-18 | Sigma-Aldrich Co., Llc | Crispr-based genome modification and regulation |
| KR102271292B1 (ko) * | 2013-03-15 | 2021-07-02 | 더 제너럴 하스피탈 코포레이션 | Rna-안내 게놈 편집의 특이성을 증가시키기 위한 rna-안내 foki 뉴클레아제(rfn)의 용도 |
| WO2015048577A2 (en) | 2013-09-27 | 2015-04-02 | Editas Medicine, Inc. | Crispr-related methods and compositions |
| US10570418B2 (en) | 2014-09-02 | 2020-02-25 | The Regents Of The University Of California | Methods and compositions for RNA-directed target DNA modification |
| WO2016049251A1 (en) * | 2014-09-24 | 2016-03-31 | The Broad Institute Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling mutations in leukocytes |
| US20180250424A1 (en) | 2014-10-10 | 2018-09-06 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| US10190106B2 (en) * | 2014-12-22 | 2019-01-29 | Univesity Of Massachusetts | Cas9-DNA targeting unit chimeras |
| CA2968939A1 (en) | 2014-12-24 | 2016-06-30 | The Johns Hopkins University | Systems and methods for genome modification and regulation |
| AU2016278226B2 (en) | 2015-06-17 | 2021-08-12 | Poseida Therapeutics, Inc. | Compositions and methods for directing proteins to specific loci in the genome |
| WO2016210271A1 (en) | 2015-06-24 | 2016-12-29 | Sigma-Aldrich Co. Llc | Cell cycle dependent genome regulation and modification |
| CN107922953B (zh) | 2015-08-20 | 2022-03-04 | 应用干细胞有限公司 | 提高基因编辑效率的核酸酶 |
| US9926546B2 (en) | 2015-08-28 | 2018-03-27 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
| SG11201911864PA (en) | 2017-07-11 | 2020-01-30 | Sigma Aldrich Co Llc | Using nucleosome interacting protein domains to enhance targeted genome modification |
-
2018
- 2018-07-10 SG SG11201911864PA patent/SG11201911864PA/en unknown
- 2018-07-10 KR KR1020237012751A patent/KR102655021B1/ko active Active
- 2018-07-10 IL IL271197A patent/IL271197B2/en unknown
- 2018-07-10 WO PCT/US2018/041454 patent/WO2019014230A1/en not_active Ceased
- 2018-07-10 CN CN201880046339.1A patent/CN111183226A/zh active Pending
- 2018-07-10 IL IL309801A patent/IL309801B2/en unknown
- 2018-07-10 US US16/031,819 patent/US10604752B2/en active Active
- 2018-07-10 KR KR1020247010966A patent/KR20240046316A/ko active Pending
- 2018-07-10 JP JP2020501142A patent/JP6994560B2/ja active Active
- 2018-07-10 CA CA3066790A patent/CA3066790C/en active Active
- 2018-07-10 AU AU2018299995A patent/AU2018299995B2/en active Active
- 2018-07-10 KR KR1020207002645A patent/KR102523217B1/ko active Active
- 2018-07-11 PL PL21193940.0T patent/PL3988656T3/pl unknown
- 2018-07-11 PL PL18182999T patent/PL3428274T3/pl unknown
- 2018-07-11 GB GB2114520.6A patent/GB2598847B/en active Active
- 2018-07-11 LT LTEP18182999.5T patent/LT3428274T/lt unknown
- 2018-07-11 PT PT211939400T patent/PT3988656T/pt unknown
- 2018-07-11 PT PT181829995T patent/PT3428274T/pt unknown
- 2018-07-11 GB GB1811358.9A patent/GB2567917B/en active Active
- 2018-07-11 DK DK18182999.5T patent/DK3428274T3/da active
- 2018-07-11 GB GB2103935.9A patent/GB2593814B/en active Active
- 2018-07-11 EP EP21193940.0A patent/EP3988656B9/en active Active
- 2018-07-11 ES ES18182999T patent/ES2901629T3/es active Active
- 2018-07-11 DK DK21193940.0T patent/DK3988656T3/da active
- 2018-07-11 EP EP18182999.5A patent/EP3428274B1/en active Active
- 2018-07-11 LT LTEP21193940.0T patent/LT3988656T/lt unknown
- 2018-07-11 ES ES21193940T patent/ES2997490T3/es active Active
- 2018-07-11 FI FIEP21193940.0T patent/FI3988656T3/fi active
-
2020
- 2020-02-18 US US16/793,272 patent/US12065642B2/en active Active
- 2020-02-18 US US16/793,253 patent/US12221606B2/en active Active
-
2021
- 2021-10-06 AU AU2021245148A patent/AU2021245148B2/en active Active
- 2021-12-13 JP JP2021201415A patent/JP7469285B2/ja active Active
-
2022
- 2022-02-09 AU AU2022200851A patent/AU2022200851B2/en active Active
-
2024
- 2024-04-04 JP JP2024060701A patent/JP2024096783A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3428274T3 (da) | Anvendelse af nukleosominteragerende proteindomæner til forbedring af målrettet genommodifikation | |
| IL290809A (en) | Tau-protein targeting protacs and associated methods of use | |
| IL286888A (en) | Use of pridopidine to treat depression or anxiety | |
| DK3604527T3 (da) | Anvendelse af programmerbare dna-bindingsproteiner til at forbedre målrettet genommodifikation | |
| EP3678681A4 (en) | INTERLEUKIN-18 VARIANTS AND THEIR PROCEDURES FOR USE | |
| IL256079A (en) | Humanized and affinity matured antibodies to fcrh5 and methods of use | |
| PL3353210T3 (pl) | Przeciwciała anty-TIGIT i sposoby stosowania | |
| DK3515478T3 (da) | Antistoffer til SIGLEC-15 og fremgangsmåder til anvendelse deraf | |
| PT3250610T (pt) | Anticorpos de fcrn e métodos de utilização dos mesmos | |
| EP3377059A4 (en) | INHIBITORS OF CXCR2 | |
| EA201691974A1 (ru) | Антитела против ox40 и способы их применения | |
| ME03335B (me) | Konstrukti uspa2 proteina i njihove upotrebe | |
| EA201691610A1 (ru) | Анти-jagged1 антитела и способы применения | |
| IL269540A (en) | Purification of phycobiliproteins | |
| IL268731A (en) | New uses of anti-sirpg antibodies | |
| EP3314503A4 (en) | SIMULATION OF AN APPLICATION | |
| PL3565828T3 (pl) | Białko fuzyjne SIRP1 ALFA-41BBL i sposoby jego zastosowania | |
| EP3578165A4 (en) | IRREGULARITY CORRECTION COSMETIC PRODUCT | |
| DK3259349T3 (da) | Dehydrogenase-katalyseret fremstilling af FDCA | |
| IL272851A (en) | Methods of using dipivefrin | |
| DK3099800T3 (da) | Ekspression og oprensning af crm197 og beslægtede proteiner | |
| DK3166628T3 (da) | Terapeutisk anvendelse af knoglemorfogenetiske proteiner | |
| EP3602547C0 (en) | TARGET SAMPLE GENERATION | |
| IL283136A (en) | Antibodies to mucin-16 and methods of use thereof | |
| EP3630046C0 (en) | ANTI-DOUBLECORTIN-LIKE KINASE 1 ANTIBODIES AND METHODS OF USE THEREOF |